drugset / Trial / NCT06487455
A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of SPH7485 tablets in patients with advanced solid tumors.
Timeline
- Start
- 2024-08-06
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPH7485 | Unknown | 50 mg | Oral |
| Subject | SPH7485 | Unknown | 400 mg | Oral |